Details for New Drug Application (NDA): 019500
✉ Email this page to a colleague
NDA 019500 describes LAMPRENE, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the LAMPRENE profile page.
The generic ingredient in LAMPRENE is clofazimine. There are five drug master file entries for this compound. Additional details are available on the clofazimine profile page.
The generic ingredient in LAMPRENE is clofazimine. There are five drug master file entries for this compound. Additional details are available on the clofazimine profile page.
Summary for 019500
| Tradename: | LAMPRENE |
| Applicant: | Novartis |
| Ingredient: | clofazimine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019500
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Dec 15, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Dec 15, 1986 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
